Alpha Cognition Inc. Capital Expenditures
Alpha Cognition Inc. (ACOG) reported Capital Expenditures of $99.89 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-13
- Alpha Cognition Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $98.57K, a 1085.45% increase year-over-year.
- Alpha Cognition Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $1.32K, a 97.91% decline year-over-year.
- Alpha Cognition Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $147.52K.
- Alpha Cognition Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $74.38K.
- Alpha Cognition Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $293.49K, a 999.17% increase from fiscal 2024.
- Alpha Cognition Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $26.70K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $98.57K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $99.89K 10-Q · filed 2026-08-13 | $247.41K derived: sum of 3 quarters · filed 2026-08-13 | $321.80K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $1.32K 10-Q · filed 2026-05-14 | $148.84K derived: sum of 2 quarters · filed 2026-05-14 | $223.23K derived: sum of 3 quarters · filed 2026-05-14 | $231.54K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $147.52K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $221.90K derived: sum of 2 quarters · filed 2026-03-31 | $230.22K derived: sum of 3 quarters · filed 2026-08-13 | $293.49K 10-K · filed 2026-03-31 |
| 2025-09-30 | $74.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $82.70K derived: sum of 2 quarters · filed 2026-08-13 | $145.97K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $8.31K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $71.58K 10-Q · filed 2026-08-13 | ||
| 2025-03-31 | $63.27K 10-Q · filed 2026-05-14 | |||
| 2024-12-31 | $26.70K 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |